Is Glucomannan Dietary Fiber Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Glucomannan Dietary Fiber Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Obesity is a globally prevalent metabolic disorder closely associated with gut microbiota dysbiosis. [Hu B (2026); evidence level 4] - faecium or exogenous LEA supplementation improved obesity-associated metabolic phenotypes. [Hu B (2026); evidence level 4] - Furthermore, using a high-content screening system and an in vitro fermentation model, we found that the dietary fiber glucomannan exerted anti-obesity effects by promoting the growth of E. [Hu B (2026); evidence level 4] - However, the precise roles of gut microbiota and microbial metabolism in this disease remain unclear. [Hu B (2026); evidence level 4] - Effects of OKGM on metabolic health was evaluated by a 13-week oral toxicity study in ICR mice, in compliance with OECD Guideline 408 (OECD, 1998). [Li Yao (2024); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.